Ciro Celsa, Naoshi Nishida, Shadi Chamseddine, Ashwini Arvind, Michael Li, Hidenori Toyoda, Susanna Varkey Ulahannan, Claudia A.M. Fulgenzi, Giulia F Manfredi, Antonio D'Alessio, Bernardo Stefanini, Giuseppe Cabibbo, Calogero Cammà, Bernhard Scheiner, Lorenza Rimassa, Robin Kate Kelley, Amit Singal, Ahmed Omar Kaseb, Masatoshi Kudo, David James Pinato. "Outcomes of durvalumab (D) with or without tremelimumab (T) in routine clinical practice according to HIMALAYA trial eligibility: Preliminary results of the international DT-real study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.552